Skip to main content
Program
#ScientificSessions26
Late-Breaking Science
Daily Coverage
Industry Highlights
Journeys
Late-Breaking Science
Cardiometabolic and lifestyle interventions for AFib
Latest innovations designed to optimize arrhythmia care
Potential changes in the cardiometabolic risk reduction landscape
Late-breaking trials showcase AI’s potential as a cardiovascular disease screening and diagnostic tool
Reports find multiple approaches improve outcomes after stroke
Late-breaking trials challenge conventional treatments to cardiovascular disease
Lessons from landmark trials
Sponsored
Join our Novo symposium exploring GLP-1RAs in cardiovascular disease
‘A change of heart: Rethinking cardiovascular care with GLP-1RAs’, featuring Stephen Greene, Leigh Perreault and Orly Vardeny
#ScientificSessions26 Late-Breaking Science announced
Six sessions during the meeting are devoted to the presentation of the latest research results.
Approaches to ischemic heart disease before, during and after hospitalization
Findings in heart failure late-breaking research
Practice-changing trials in blood pressure control
Get Scientific Sessions OnDemand
Unlimited access begins December 2025.
Cutting-edge valve and coronary trials
Antithrombotic therapy in AFib care post procedures
Groundbreaking trials in cardiometabolic therapeutics
Experience Scientific Sessions at #AHA25
View Experience Guide
Get inspired at Scientific Sessions' Main Events
Abstracts reveal research, results
Enrich your Scientific Sessions experience
Late-Breaking Science sessions: Where breakthroughs are announced
Advances in lipid therapeutics
New approaches to managing AFib
Medical therapy for heart failure
Innovation in prevention
Harnessing AI for better heart health
Coronary and valvular heart disease